K230474

Substantially Equivalent

EVA5 Insufflator

Applicant: Palliare , Ltd.
Product code: FCX
Advisory panel: Gastroenterology, Urology
Date received: 2023-02-22
Decision date: 2023-03-24
Decision: Substantially Equivalent
Clearance type: Special
Location: Galway, IE

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.